Shane A. Bobart, MD

Assistant Professor of Medicine, Academic Institute
Assistant Clinical Member, Research Institute
Associate Program Director, Nephrology Fellowship, Department of Medicine
Houston Methodist
Weill Cornell Medical College


Nephrology Fellowship


Biography

Dr. Bobart received his medical degree from St. George’s University, in Grenada, followed by Internal Medicine residency training at Cleveland Clinic Florida. Dr. Bobart completed his Nephrology fellowship at Mayo Clinic and a Certificate in Clinical and Translational Science from the Mayo Clinic College of Medicine and Science. Dr. Bobart then joined the Nephrology Department at Cleveland Clinic Florida in 2020, where he was the Associate Program Director of the Nephrology fellowship, Core Faculty of the Internal Medicine Residency Program and Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, a position he held until 2023 when he moved to Houston Methodist Hospital.

Description of Research

Dr. Bobart is a Clinician-Scientist focused on Glomerular disease and epidemiological research. He has been funded by the Cleveland Clinic Caregiver Catalyst award and Cleveland Clinic Florida Regional grants. Dr. Bobart has served as faculty for the GlomCon (Glomerular Diseases Consortium) International Fellowship.

Publications

The Clinical and Pathological Characteristics of Patients with Oxalate Nephropathy
Llanos, M, Kwon, A, Herlitz, L, Shafi, T, Cohen, S, Gebreselassie, SK, Sawaf, H & Bobart, SA 2024, , Kidney360, vol. 5, no. 1, pp. 65-72. https://doi.org/10.34067/KID.0000000000000340

Maintenance of Remission and Risk of Relapse in Myeloperoxidase-Positive ANCA-Associated Vasculitis with Kidney Involvement
Moura, MC, Specks, U, Tehranian, S, Sethi, S, Zubidat, D, Nardelli, L, Dos Santos, FG, Sousa, C, León-Róman, J, Bobart, SA, Greene, E, Zand, L & Fervenza, FC 2023, , Clinical Journal of the American Society of Nephrology, vol. 18, no. 1, pp. 47-59. https://doi.org/10.2215/CJN.06460622

Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management
Sawaf, H, Gudura, TT, Dorobisz, S, Sandy, D, Wang, X & Bobart, SA 2023, , International Journal of Nephrology and Renovascular Disease, vol. 16, pp. 1-15. https://doi.org/10.2147/IJNRD.S363041

The Cleveland Clinic Kidney Biopsy Epidemiological Project
Bobart, SA, Portalatin, G, Sawaf, H, Shettigar, S, Carrion-Rodriguez, A, Liang, H, Herlitz, L & Gebreselassie, SK 2022, , Kidney360, vol. 3, no. 12, pp. 2077-2085. https://doi.org/10.34067/KID.0005882022

Ketogenic-Diet Shake Containing Uncaria tomentosa -Associated Acute Interstitial Nephritis
Portalatin, G, Shettigar, S, Carrion-Rodriguez, A, Medikayala, S, Herlitz, L, Sandy, D, Gebreselassie, SK & Bobart, SA 2022, , Case Reports in Nephrology and Dialysis, vol. 12, no. 3, pp. 219-225. https://doi.org/10.1159/000526391

Lupus nephritis – An update on disparities affecting african americans
Portalatin, GM, Gebreselassie, SK & Bobart, SA 2022, , Journal of the National Medical Association, vol. 114, no. 3, pp. S34-S42. https://doi.org/10.1016/j.jnma.2022.05.005

Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy A Validation Study
Bobart, SA, Han, H, Tehranian, S, De Vriese, AS, Roman, JCL, Sethi, S, Zand, L, Gomez, CA, Giesen, CD, Soler, MJ, Bomback, AS & Fervenza, FC 2021, , Clinical Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 1833-1839. https://doi.org/10.2215/CJN.05480421

1H Nuclear Magnetic Resonance Spectroscopy-Based Methods for the Quantification of Proteins in Urine
Vuckovic, I, Denic, A, Charlesworth, MC, Šuvakov, M, Bobart, S, Lieske, JC, Fervenza, FC & Macura, S 2021, , Analytical Chemistry, vol. 93, no. 39, pp. 13177-13186. https://doi.org/10.1021/acs.analchem.1c01618

The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy
Bobart, SA, Alexander, MP, Shawwa, K, Vaughan, LE, Ghamrawi, R, Sethi, S, Cornell, L, Glassock, RJ, Fervenza, FC & Zand, L 2021, , Nephrology Dialysis Transplantation, vol. 36, no. 5, pp. 840-847. https://doi.org/10.1093/ndt/gfz267

New-onset atrial fibrillation in patients with acute kidney injury on continuous renal replacement therapy
Shawwa, K, Kompotiatis, P, Bobart, SA, Mara, KC, Wiley, BM, Jentzer, JC & Kashani, KB 2021, , Journal of Critical Care, vol. 62, pp. 157-163. https://doi.org/10.1016/j.jcrc.2020.12.010

A Target Antigen–Based Approach to the Classification of Membranous Nephropathy
Bobart, SA, Tehranian, S, Sethi, S, Alexander, MP, Nasr, SH, Moura Marta, C, Vrana, JA, Said, S, Giesen, CD, Lieske, JC, Fervenza, FC & De Vriese, AS 2021, , Mayo Clinic Proceedings, vol. 96, no. 3, pp. 577-591. https://doi.org/10.1016/j.mayocp.2020.11.028

Recurrent glomerulonephritis in the kidney allograft
Bobart, SA, Alexander, MP & Bentall, A 2020, , Indian Journal of Nephrology, vol. 30, no. 6, pp. 359-369. https://doi.org/10.4103/ijn.IJN_193_19

Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity
Nephrotic Syndrome Study Network Consortium (NEPTUNE) 2020, , Kidney International Reports, vol. 5, no. 11, pp. 2021-2031. https://doi.org/10.1016/j.ekir.2020.08.001

Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series
El Ters, M, Bobart, SA, Cornell, LD, Leung, N, Bentall, A, Sethi, S, Fidler, M, Grande, J, Hernandez, LH, Cosio, FG, Zand, L, Amer, H, Fervenza, FC, Nasr, SH & Alexander, MP 2020, , American Journal of Kidney Diseases, vol. 76, no. 4, pp. 500-510. https://doi.org/10.1053/j.ajkd.2020.01.018

Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R1 and Normal Kidney Function: The Con View
Bobart, SA 2020, , Kidney360, vol. 1, no. 9, pp. 890-893. https://doi.org/10.34067/KID.0003262020

Immune Check Point Inhibitor–Associated Endothelialitis
Bobart, SA, Owoyemi, I, Grande, J, Leung, N & Herrmann, SM 2020, , Kidney International Reports, vol. 5, no. 8, pp. 1371-1374. https://doi.org/10.1016/j.ekir.2020.05.027

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ (EBioMedicine (2019) 47 (446–456), (S2352396419305912), (10.1016/j.ebiom.2019.08.069))
Hickson, LTJ, Langhi Prata, LGP, Bobart, SA, Evans, TK, Giorgadze, N, Hashmi, SK, Herrmann, SM, Jensen, MD, Jia, Q, Jordan, KL, Kellogg, TA, Khosla, S, Koerber, DM, Lagnado, AB, Lawson, DK, LeBrasseur, NK, Lerman, LO, McDonald, KM, McKenzie, TJ, Passos, JF, Pignolo, RJ, Pirtskhalava, T, Saadiq, IM, Schaefer, KK, Textor, SC, Victorelli, SG, Volkman, TL, Xue, A, Wentworth, MA, Wissler Gerdes, EO, Allison, DB, Dickinson, SL, Ejima, K, Atkinson, EJ, Lenburg, M, Zhu, Y, Tchkonia, T & Kirkland, JL 2020, , EBioMedicine, vol. 52, 102595. https://doi.org/10.1016/j.ebiom.2019.12.004

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Hickson, LTJ, Langhi Prata, LGP, Bobart, SA, Evans, TK, Giorgadze, N, Hashmi, SK, Herrmann, SM, Jensen, MD, Jia, Q, Jordan, KL, Kellogg, TA, Khosla, S, Koerber, DM, Lagnado, AB, Lawson, DK, LeBrasseur, NK, Lerman, LO, McDonald, KM, McKenzie, TJ, Passos, JF, Pignolo, RJ, Pirtskhalava, T, Saadiq, IM, Schaefer, KK, Textor, SC, Victorelli, SG, Volkman, TL, Xue, A, Wentworth, MA, Wissler Gerdes, EO, Zhu, Y, Tchkonia, T & Kirkland, JL 2019, , EBioMedicine, vol. 47, pp. 446-456. https://doi.org/10.1016/j.ebiom.2019.08.069

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies
Bobart, SA, De Vriese, AS, Pawar, AS, Zand, L, Sethi, S, Giesen, C, Lieske, JC & Fervenza, FC 2019, , Kidney international, vol. 95, no. 2, pp. 429-438. https://doi.org/10.1016/j.kint.2018.10.021

C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
Bobart, SA, Sethi, S & Fervenza, FC 2019, , Kidney Medicine, vol. 1, no. 1, pp. 36-39. https://doi.org/10.1016/j.xkme.2018.12.002